Apr 23, 2018 - Let's dig into the earnings picture of the companies that would drive the performance of the popular health care ETFs in the coming days.
Apr 23, 2018 - Bristol-Myers (BMY) is scheduled to report Q1 earnings on Apr 26.
Apr 23, 2018 - Seeking Alpha helps retirees and future retirees face current issues.Today, I will be going over investor priorities and fears when planning for the future.Dividend investing is a great source of inco
Apr 23, 2018 - Tagrisso is approved in the United States, European Union, Japan and China as second-line treatment for patients with advanced NSCLC.
Apr 22, 2018 - Week 10 sees some more decline, including in the blue-chip Bristol-Myers.Some movement was observed in our midcaps.Mostly the stocks continue to hold, too high or low to reach targets, but this could
Apr 22, 2018 - Solid Biosciences rallied aggressively, as the company is experiencing increasing industry tailwinds. The temporary concerns re gene editing and therapy are now abated.Despite a negative binary, CellD
Apr 21, 2018 - Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday
Apr 20, 2018 - Bristol-Myers keeps the pedal down in renal cancer.AstraZeneca posts signs of life in bladder cancer immunotherapy.Calithera gains fast track in renal cell carcinoma.
Apr 20, 2018 - Novartis (NVS) and J&J (JNJ) deliver strong Q1 results. Merck (MRK) and Bristol Myers (BMY) present lung cancer data at AACR.
Apr 19, 2018 - The FDA accepts Bristol-Myers Squibb's (BMY) supplemental Biologics License Application and grants priority review for the label expansion of Opdivo to treat patients with small cell lung cancer.